LeMaitre Vascular, Inc.(LMAT): For the most recent quarter end, LeMaitre Vascular, Inc. reported Annual Earnings of $0.13. Based on the filings, last years Annual Earnings was, $0.55. For the most recent quarter end, LMAT reported a surprise Earnings per Share of -18.75% . The consensus estimate for current quarter is $0.14 and for the current fiscal year, the estimate is $0.66. For the Next fiscal year, the estimate is $0.77 based on the consensus.
LeMaitre Vascular, Inc. has received $0.14 as the consensus Earnings Estimate for the Quarter ending on Mar 2017 ,According to the estimate provided by 2 Financial Advisor in the Stock Trading Firms. Among 2 Analysts, Bottom line EPS Estimate for the current quarter is $0.14 while the top line estimate is $0.14 , a key information to consider for Day Trading and investing in stocks. The EPS growth rate is projected at 27.27%. LeMaitre Vascular, Inc. results fell short with a surprise EPS of -18.75% or $-0.03. The Actual EPS was $0.13 compared to the Estimated EPS of $0.16 during its most recent quarterly earnings.
LeMaitre Vascular, Inc. has a Price to Earnings ratio of 44.71 for the trailing twelve month period. The price to book ratio of the company for the most recent quarter is 5.24. For the Most Recent Fiscal Year, LeMaitre Vascular, Inc. has a price to cash ratio of 39.96. For the Trailing twelve month period, company showed a Net Profit Margin of 11.88% and Return on Equity of the stock is 12.7%.
LeMaitre Vascular Inc Last issued its quarterly earnings results on Feb 21, 2017. The company reported $0.13 EPS for the quarter, missing the analyst consensus estimate by $ -0.03. Analyst had a consensus of $0.16. The company had revenue of $23.30 million for the quarter, compared to analysts expectations of $23.70 million. The companys revenue was up 13.7% compared to the same quarter last year.
Company has reported several Insider transactions to the SEC, on Nov 21, 2016, David B Roberts (President and Director) sold 20,000 shares at 24.65 per share price.On Nov 18, 2016, Peter R Gebauer (President, International OP) sold 12,943 shares at 23.78 per share price.On Sep 8, 2016, George W Lemaitre (Chairman and CEO) sold 30,000 shares at 20.42 per share price.
LeMaitre Vascular, Inc. (NASDAQ:LMAT) witnessed a decline in the market cap on Wednesday as its shares dropped 9.88% or 2.43 points. After the session commenced at $21.13, the stock reached the higher end at $22.6125 while it hit a low of $19.82. With the volume soaring to 833,117 shares, the last trade was called at $22.16. The company has a 52-week high of $27.0375. The company has a market cap of $412 million and there are 18,583,768 shares in outstanding. The 52-week low of the share price is $12.355.
LEMAITRE VASCULAR, INC. is a leading global provider of innovative devices for the treatment of peripheral vascular disease. LeMaitre develops, manufactures, and markets disposable and implantable vascular devices to address the needs of vascular surgeons and interventionalists. LeMaitres diversified product portfolio consists of twelve well-known brand name products used in arteries and veins outside of the heart and are supported by a growing, specialized and highly trained organization of vascular sales professionals. LeMaitre Vascular offers a wide range of innovative products to vascular surgeons and interventionalists for improving procedure efficacy and minimizing patient recovery time.